Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
9cBNnwrjbxpW9Cgm
